Most HLB Group Stocks Fall... Only HLB Biostep Rises 2.64%, HLB Innovation Plunges 6.08%
On the morning of the 6th, most of the 10 stocks bearing the HLB name declined, with HLB Biostep the only one recording gains, according to tallies. Among the decliners, HLB Innovation posted the largest drop. HLB Biostep (278650), the sole advancer, traded at 5,440 won, up 140 won from the previou

On the morning of the 6th, most of the 10 stocks bearing the HLB name declined, with HLB Biostep the only one recording gains, according to tallies. Among the decliners, HLB Innovation posted the largest drop.
HLB Biostep (278650), the sole advancer, traded at 5,440 won, up 140 won from the previous day, a gain of 2.64%. Trading volume was 824,020 shares. The opening price was 5,020 won, with an intraday high of 5,790 won and a low of 4,795 won.
In contrast, HLB Innovation (024850) fell 950 won from the previous day to 14,680 won, a decline of 6.08% and the largest drop among the 10 HLB-named stocks. Trading volume was 56,627 shares, with an opening price of 15,170 won, a high of 15,260 won, and a low of 14,590 won.
HLB (028300) fell 850 won to 31,550 won, down 2.62%. Trading volume was 812,146 shares.
The remaining stocks were also weak across the board. HLB Global fell 2.49% to 1,525 won and HLB Life Science dropped 3.87% to 2,605 won, with trading volumes of 71,026 and 83,799 shares, respectively. HLB Pharmaceutical fell 5.35% to 7,600 won (volume: 449,237 shares), HLB Genex declined 4.12% to 1,956 won (volume: 28,853 shares), and HLB Panagen dropped 4.22% to 1,067 won (volume: 79,647 shares). HLB Therapeutics slipped 1.08% to 2,285 won, the smallest decline among the falling stocks, with a volume of 196,866 shares. HLB Pep fell 5.87% to 3,445 won, with a volume of 2,217 shares.
[This article is for reference only, based on the provided market price information, and does not constitute investment advice. Investment decisions and any resulting responsibility lie with the investor. AI provided partial assistance.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.



